Anindita Chakrabarty

3.8k total citations
88 papers, 3.0k citations indexed

About

Anindita Chakrabarty is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Anindita Chakrabarty has authored 88 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 21 papers in Oncology and 12 papers in Pharmacology. Recurrent topics in Anindita Chakrabarty's work include Phenothiazines and Benzothiazines Synthesis and Activities (17 papers), HER2/EGFR in Cancer Research (10 papers) and Bioactive Compounds and Antitumor Agents (8 papers). Anindita Chakrabarty is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (17 papers), HER2/EGFR in Cancer Research (10 papers) and Bioactive Compounds and Antitumor Agents (8 papers). Anindita Chakrabarty collaborates with scholars based in India, United States and Saudi Arabia. Anindita Chakrabarty's co-authors include Carlos L. Arteaga, Sujata G. Dastidar, Violeta Sánchez, Cammie Rinehart, Kumkum Ganguly, María G. Kuba, Jenny C. Chang, Bhuvanesh Dave, Sudhansu K. Dey and Susanne Tranguch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Anindita Chakrabarty

82 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anindita Chakrabarty India 31 1.6k 1.0k 548 374 315 88 3.0k
Natarajan Venkatesan United States 32 1.7k 1.0× 866 0.8× 345 0.6× 281 0.8× 115 0.4× 87 3.4k
Dianne L. Newton United States 35 3.1k 1.9× 681 0.7× 357 0.7× 466 1.2× 768 2.4× 87 4.6k
Ernesto Moreno Cuba 22 1.6k 1.0× 604 0.6× 552 1.0× 106 0.3× 486 1.5× 65 3.1k
Julie L. Eiseman United States 34 2.1k 1.3× 733 0.7× 144 0.3× 234 0.6× 302 1.0× 131 3.5k
Rehan Ahmad United States 37 2.4k 1.5× 1.0k 1.0× 360 0.7× 675 1.8× 734 2.3× 84 3.7k
Laura Masuelli Italy 37 1.9k 1.2× 679 0.7× 173 0.3× 336 0.9× 615 2.0× 128 3.9k
Christian Auclair France 38 2.5k 1.5× 588 0.6× 175 0.3× 221 0.6× 471 1.5× 143 4.5k
Haichao Zhang United States 31 3.7k 2.2× 1.1k 1.0× 142 0.3× 343 0.9× 525 1.7× 90 5.0k
Matthias Ocker Germany 39 2.9k 1.8× 1.1k 1.1× 107 0.2× 626 1.7× 342 1.1× 161 5.0k
Michael C. Alley United States 28 2.6k 1.6× 1.3k 1.3× 186 0.3× 511 1.4× 246 0.8× 48 5.2k

Countries citing papers authored by Anindita Chakrabarty

Since Specialization
Citations

This map shows the geographic impact of Anindita Chakrabarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anindita Chakrabarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anindita Chakrabarty more than expected).

Fields of papers citing papers by Anindita Chakrabarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anindita Chakrabarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anindita Chakrabarty. The network helps show where Anindita Chakrabarty may publish in the future.

Co-authorship network of co-authors of Anindita Chakrabarty

This figure shows the co-authorship network connecting the top 25 collaborators of Anindita Chakrabarty. A scholar is included among the top collaborators of Anindita Chakrabarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anindita Chakrabarty. Anindita Chakrabarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anjum, Farah, et al.. (2024). Targeting prostate cancer via therapeutic targeting of PIM-1 kinase by Naringenin and Quercetin. International Journal of Biological Macromolecules. 276(Pt 2). 133882–133882. 14 indexed citations
2.
Khan, Shama, Afzal Hussain, Mohamed F. Alajmi, et al.. (2024). Thymoquinone, artemisinin, and thymol attenuate proliferation of lung cancer cells as Sphingosine kinase 1 inhibitors. Biomedicine & Pharmacotherapy. 177. 117123–117123. 6 indexed citations
3.
Chakrabarty, Anindita, Neil E. Bhola, Vishnu S. Mishra, et al.. (2019). The H1047R PIK3CA oncogene induces a senescence-like state, pleiotropy and acute HSP90 dependency in HER2+ mammary epithelial cells. Carcinogenesis. 40(10). 1179–1190. 7 indexed citations
4.
Chakrabarty, Anindita, Neil E. Bhola, Cammie R. Sutton, et al.. (2012). Trastuzumab-Resistant Cells Rely on a HER2-PI3K-FoxO-Survivin Axis and Are Sensitive to PI3K Inhibitors. Cancer Research. 73(3). 1190–1200. 101 indexed citations
5.
Ghosh, Ritwik, Archana Narasanna, Anindita Chakrabarty, Jeffrey A. Engelman, & Carlos L. Arteaga. (2012). Abstract 3: HER2 gene-amplified human breast cancer cells harboring a gatekeeper T768M mutation in HER2 overexpress EGFR ligands and are sensitive to dual therapeutic blockade of EGFR and HER2. Cancer Research. 72(8_Supplement). 3–3. 2 indexed citations
6.
Chakrabarty, Anindita, Violeta Sánchez, María G. Kuba, Cammie Rinehart, & Carlos L. Arteaga. (2011). Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors. Proceedings of the National Academy of Sciences. 109(8). 2718–2723. 276 indexed citations
7.
Cook, Rebecca S., Joan T. Garrett, Violeta Sánchez, et al.. (2011). ErbB3 Ablation Impairs PI3K/Akt-Dependent Mammary Tumorigenesis. Cancer Research. 71(11). 3941–3951. 64 indexed citations
8.
Garrett, Joan T., Maria G. Olivares, Cammie Rinehart, et al.. (2011). Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase. Proceedings of the National Academy of Sciences. 108(12). 5021–5026. 359 indexed citations
9.
Ghosh, Ritwik, Archana Narasanna, Shizhen Emily Wang, et al.. (2011). Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers. Cancer Research. 71(5). 1871–1882. 171 indexed citations
10.
11.
Daikoku, Takiko, Susanne Tranguch, Anindita Chakrabarty, et al.. (2007). Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-δ Signaling in Epithelial Ovarian Cancer. Cancer Research. 67(11). 5285–5292. 39 indexed citations
12.
Chakrabarty, Anindita, Susanne Tranguch, Takiko Daikoku, et al.. (2007). MicroRNA regulation of cyclooxygenase-2 during embryo implantation. Proceedings of the National Academy of Sciences. 104(38). 15144–15149. 229 indexed citations
13.
Dutta, Noton K., Kaushiki Mazumdar, Sujata G. Dastidar, et al.. (2005). In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA.. PubMed. 19(3). 539–45. 11 indexed citations
14.
Chakrabarty, Anindita, et al.. (2002). Experimental Studies on Synergism Between Aminoglycosides and the Antimicrobial Antiinflammatory Agent Diclofenac Sodium. Journal of Chemotherapy. 14(1). 47–53. 33 indexed citations
15.
Dastidar, S. G., et al.. (1995). In VitroandIn VivoAntimicrobial Action of Fluphenazine. Journal of Chemotherapy. 7(3). 201–206. 44 indexed citations
16.
Chakrabarty, Anindita, et al.. (1990). Reported in vivo structures found in LL cases correlate with the morphological entities of in vitro cultures.. PubMed. 62(2). 223–5.
17.
Chakrabarty, Anindita, Dhruba Acharya, Devdatta Suhas Neogi, & S. G. Dastidar. (1989). Drug interaction of promethazine & other non-conventional antimicrobial chemotherapeutic agents.. PubMed. 89. 233–7. 28 indexed citations
18.
Dastidar, Sujata G., et al.. (1976). Antibacterial Activity of Ambodryl and Benadryl. Journal of Applied Bacteriology. 41(2). 209–214. 38 indexed citations
19.
Dastidar, S. G., et al.. (1974). Transformation with Bacteriocin Factors in Staphylococci. Journal of General Microbiology. 84(2). 245–252. 3 indexed citations
20.
Chakrabarty, Anindita, et al.. (1970). The Hydrolysis of Tween 80 by Vibrios and Aeromonads. Journal of Applied Bacteriology. 33(2). 397–402. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natarajan Venkatesan Breakdown of academic impact, for papers by Dianne L. Newton Breakdown of academic impact, for papers by Ernesto Moreno Breakdown of academic impact, for papers by Julie L. Eiseman Breakdown of academic impact, for papers by Rehan Ahmad Breakdown of academic impact, for papers by Laura Masuelli Breakdown of academic impact, for papers by Christian Auclair Breakdown of academic impact, for papers by Haichao Zhang Breakdown of academic impact, for papers by Matthias Ocker Breakdown of academic impact, for papers by Michael C. Alley
Rankless by CCL
2026